3431 - 3440 of 6230 Results
Title
Year
- Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein2020OPENTitle: Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00380-wBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00380-wCitation Count: 13
- Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein2020OPENTitle: Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synucleinJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aba1193Best OA location URL: https://advances.sciencemag.org/content/advances/6/18/eaba1193.full.pdfCitation Count: 58
- Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s2025OPENTitle: Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’sJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 272Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-024-12789-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-024-12789-0.pdfCitation Count: 5
- Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis2021OPENTitle: Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease PsychosisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.633645Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.633645/pdfCitation Count: 7
- Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson’s disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004)2022OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson’s disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 61Issue #:Start Page: 102765End Page: 102765Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102765Best OA location URL: https://doi.org/10.1016/j.scr.2022.102765Citation Count: 3
- An immersive virtual reality shopping task detects declines in instrumental activities of daily living in individuals with Parkinson's disease2024OPENTitle: An immersive virtual reality shopping task detects declines in instrumental activities of daily living in individuals with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 125Issue #:Start Page: 107019End Page: 107019Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107019Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107019Citation Count: 2
- Modeling and optimizing deep brain stimulation to enhance gait in Parkinson’s disease: personalized treatment with neurophysiological insights2025OPENTitle: Modeling and optimizing deep brain stimulation to enhance gait in Parkinson’s disease: personalized treatment with neurophysiological insightsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00990-5Best OA location URL: https://www.nature.com/articles/s41531-025-00990-5.pdfCitation Count: 0
- The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation2021OPENTitle: The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregationJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01256-wBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01256-wCitation Count: 11
- Genome-wide meta-analysis of short-tandem repeats for Parkinson’s disease risk using genotype imputation2024OPENTitle: Genome-wide meta-analysis of short-tandem repeats for Parkinson’s disease risk using genotype imputationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae146Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae146/57311805/fcae146.pdfCitation Count: 1
-
OPENTitle: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s diseaseJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 215Issue #: 9Start Page: 2247End Page: 2264Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1084/jem.20180484Best OA location URL: https://rupress.org/jem/article-pdf/215/9/2247/1171465/jem_20180484.pdfCitation Count: 65